QTR Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Sell
21,847
-161
-0.7% -$9.24K 0.44% 47
2026
Q1
$1.28M Buy
22,008
+2,263
+11% +$132K 0.53% 41
2025
Q4
$1.2M Buy
19,745
+10,463
+113% +$503K 0.53% 38
2025
Q3
$419K Buy
9,282
+741
+9% +$34.6K 0.2% 113
2025
Q2
$395K Buy
8,541
+1,911
+29% +$93.8K 0.24% 94
2025
Q1
$404K Buy
+6,630
New +$386K 0.3% 90

Other funds holding BMY

QTR Family Wealth's BMY Position: Q2 2026 in Review

QTR Family Wealth reduced its Bristol-Myers Squibb (BMY) stake by 0.73% in Q2 2026, selling an estimated $9.24K and leaving 21,847 shares worth $1.26M. The position accounts for 0.44% of the portfolio, ranked #47.

QTR Family Wealth first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.28M in Q1 2026. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • QTR Family Wealth held 21,847 shares of Bristol-Myers Squibb worth $1.26M as of Q2 2026.
  • QTR Family Wealth sold 161 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.24K.
  • Bristol-Myers Squibb made up 0.44% of QTR Family Wealth's portfolio in Q2 2026, its #47 holding.
  • QTR Family Wealth first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
  • QTR Family Wealth's Bristol-Myers Squibb position peaked at $1.28M in Q1 2026.
  • 889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on QTR Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.